相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Systematic review: predicting and optimising response to anti-TNF therapy in Crohn's disease - algorithm for practical management
N. S. Ding et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Ustekinumab for the treatment of Crohn's disease: can it find its niche?
Ebby G. Simon et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2016)
Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn's Disease Refractory to Anti-Tumor Necrosis Factor Agents
Pauline Wils et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis
Stefanos Bonovas et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Patients with Refractory Crohn's Disease Successfully Treated with Ustekinumab
Kimberly A. Harris et al.
INFLAMMATORY BOWEL DISEASES (2016)
Optimizing Treatment with TNF Inhibitors in Inflammatory Bowel Disease by Monitoring Drug Levels and Antidrug Antibodies
Casper Steenholdt et al.
INFLAMMATORY BOWEL DISEASES (2016)
Vedolizumab in the Treatment of the Ulcerative Colitis and the Crohn's disease, a Consensus of the Working Group Chronic Inflammatory Bowel Disease of the Austrian Society for Gastroenterology and Hepatology
G. Novacek et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2016)
Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Factors Associated with Durable Response to Infliximab in Crohn's Disease 5 Years and Beyond: A Multicenter International Cohort
Pascal Juillerat et al.
INFLAMMATORY BOWEL DISEASES (2015)
European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies
Vito Annese et al.
JOURNAL OF CROHNS & COLITIS (2015)
Infliximab Top-Down Strategy is Superior to Step-Up in Maintaining Long-Term Remission in the Treatment of Pediatric Crohn Disease
Yoo Min Lee et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2015)
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial
Reena Khanna et al.
LANCET (2015)
Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn's Disease
Giovanni Monteleone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Optimizing the use of biological therapy in patients with inflammatory bowel disease
Alan C. Moss
GASTROENTEROLOGY REPORT (2015)
An update on medical management on Crohn's disease
Andrea Affronti et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
Treatment algorithms in Crohn's - Up, down or something else?
Ophelie Antunes et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2014)
Postoperative Therapy With Infliximab Prevents Long-term Crohn's Disease Recurrence
Miguel Regueiro et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Increased Risk of Malignancy With Adalimumab Combination Therapy, Compared With Monotherapy, for Crohn's Disease
Mark T. Osterman et al.
GASTROENTEROLOGY (2014)
Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer
Laurent Beaugerie et al.
GUT (2014)
Report of successful use of ustekinumab in Crohn's disease refractory to three anti-TNF therapies
Z. S. Heetun et al.
IRISH JOURNAL OF MEDICAL SCIENCE (2014)
Subcutaneous ustekinumab for the treatment of anti-TNF resistant Crohn's disease-The McGill experience
U. Kopylov et al.
JOURNAL OF CROHNS & COLITIS (2014)
Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
J. F. Rahier et al.
JOURNAL OF CROHNS & COLITIS (2014)
Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial
Severine Vermeire et al.
LANCET (2014)
In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease
Raja Atreya et al.
NATURE MEDICINE (2014)
Crohn's disease and growth deficiency in children and adolescents
Marco Gasparetto et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Updated German Clinical Practice Guideline on Diagnosis and treatment of Crohn's disease 2014 AWMF registration no.: 021-004
J. C. Preiss et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2014)
Mucosal healing as a treatment for IBD?
Claudio Papi et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2014)
Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE
R. Panaccione et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Opportunistic Infections With Anti-Tumor Necrosis Factor-α Therapy in Inflammatory Bowel Disease: Meta-Analysis of Randomized Controlled Trials
Alexander C. Ford et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Top-Down or Step-Up Treatment in Crohn's Disease?
Gerhard Rogler
DIGESTIVE DISEASES (2013)
Early Administration of Azathioprine vs Conventional Management of Crohn's Disease: A Randomized Controlled Trial
Jacques Cosnes et al.
GASTROENTEROLOGY (2013)
Early Azathioprine Therapy Is No More Effective Than Placebo for Newly Diagnosed Crohn's Disease
Julian Panes et al.
GASTROENTEROLOGY (2013)
Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3 years for adalimumab-treated patients with early Crohn's disease
S. Schreiber et al.
JOURNAL OF CROHNS & COLITIS (2013)
Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial
Paul Rutgeerts et al.
GASTROENTEROLOGY (2012)
Mucosal healing in inflammatory bowel diseases: a systematic review
Markus F. Neurath et al.
GUT (2012)
Efficacy of Early Infliximab Treatment for Pediatric Crohn's Disease: A Three-year Follow-up
Yun Seok Lee et al.
PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION (2012)
Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti-Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease
Mario Cottone et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease
David S. Kotlyar et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Development of the Crohn's Disease Digestive Damage Score, the Lemann Score
Benjamin Pariente et al.
INFLAMMATORY BOWEL DISEASES (2011)
Surgery in Children With Crohn Disease Refractory to Medical Therapy
Maurizio Pacilli et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2011)
Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease
Filip Baert et al.
GASTROENTEROLOGY (2010)
Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates
A. V. Ramadas et al.
GUT (2010)
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease.
Jean Frederic Colombel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies
M. Allez et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Infliximab Prevents Crohn's Disease Recurrence After Ileal Resection
Miguel Regueiro et al.
GASTROENTEROLOGY (2009)
Risk factors for opportunistic infections in patients with inflammatory bowel disease
Murat Toruner et al.
GASTROENTEROLOGY (2008)
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease:: an open randomised trial
Geert D'Haens et al.
LANCET (2008)
Clinical course in Crohn's disease: Results of a Norwegian population-based ten-year follow-up study
Inger Camilla Solberg et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Early versus late surgery for ileo-caecal Crohn's disease
A. Aratari et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Long-term clinical results of ileocecal resection for Crohn's disease
Garret Cullen et al.
INFLAMMATORY BOWEL DISEASES (2007)
Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease
Severine Vermeire et al.
GUT (2007)
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial
Jean-Frederic Colombel et al.
GASTROENTEROLOGY (2007)
Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry
GR Lichtenstein et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)
A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease
J Markowitz et al.
GASTROENTEROLOGY (2000)
分享论文
